• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感病毒血凝素的自旋标记可用于分析低pH下的构象变化及其被抗体抑制的情况。

Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody.

作者信息

Yoden S, Kida H, Kuwabara M, Yanagawa R, Webster R G

出版信息

Virus Res. 1986 May;4(3):251-61. doi: 10.1016/0168-1702(86)90004-3.

DOI:10.1016/0168-1702(86)90004-3
PMID:3017016
Abstract

To study the conformational changes in the hemagglutinin (HA) molecule of A/seal/Mass/1/80 (H7N7) (Seal) influenza virus at low pH, a spin-labeling method was used. This method also permits study of antibody interaction with the HA. A synthetic nitroxide compound was used for spin-labeling of tyrosine residues of the isolated HA molecule. Electron spin resonance (ESR) spectra of the spin-labeled HA at various pH values indicated that a conformational transition occurred under acidic conditions, and around pH 5.8 the HA molecule has maximal flexibility. Since virus-induced hemolysis occurs optimally at pH 5.8-5.9, the HA molecule in the maximally flexible conformation is considered to mediate membrane fusion. The ESR spectra of the antibody-bound HA at various pH values revealed that monoclonal antibodies to different regions on the molecule may inhibit the conformational change by different modes. One antibody inhibited the changes in the HA that resulted in flexibility, while the other did not. These results support the assumption that monoclonal antibodies, which failed to inhibit hemagglutination of the virus yet neutralized viral infectivity, inhibited the fusion step in the viral replication process by interfering with a low pH-induced conformational change in the HA molecule (Kida, H., Webster, R.G. and Yanagawa, R. (1983) Arch. Virol. 76, 91-99).

摘要

为研究A/海豹/马萨诸塞/1/80(H7N7)(海豹型)流感病毒血凝素(HA)分子在低pH值下的构象变化,采用了自旋标记法。该方法还可用于研究抗体与HA的相互作用。一种合成的氮氧化物化合物用于对分离出的HA分子的酪氨酸残基进行自旋标记。不同pH值下自旋标记HA的电子自旋共振(ESR)光谱表明,在酸性条件下发生了构象转变,在pH 5.8左右HA分子具有最大的灵活性。由于病毒诱导的溶血在pH 5.8 - 5.9时最佳发生,因此处于最大灵活构象的HA分子被认为介导膜融合。不同pH值下抗体结合HA的ESR光谱显示,针对分子不同区域的单克隆抗体可能通过不同方式抑制构象变化。一种抗体抑制了导致灵活性的HA变化,而另一种则没有。这些结果支持了这样的假设,即未能抑制病毒血凝但能中和病毒感染性的单克隆抗体,通过干扰低pH诱导的HA分子构象变化,抑制了病毒复制过程中的融合步骤(木田浩、韦伯斯特·R·G、柳川润(1983年)《病毒学文献》76卷,91 - 99页)。

相似文献

1
Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody.流感病毒血凝素的自旋标记可用于分析低pH下的构象变化及其被抗体抑制的情况。
Virus Res. 1986 May;4(3):251-61. doi: 10.1016/0168-1702(86)90004-3.
2
Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin.流感病毒与内体膜的融合受到针对血凝素上特定表位的单克隆抗体的抑制。
Virus Res. 1998 Feb;53(2):129-39. doi: 10.1016/s0168-1702(97)00143-3.
3
Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH.H3流感病毒血凝素分子在酸性pH值下的抗原性变化。
Virology. 1983 Apr 30;126(2):587-99. doi: 10.1016/s0042-6822(83)80015-4.
4
Interference with a conformational change in the haemagglutinin molecule of influenza virus by antibodies as a possible neutralization mechanism.抗体干扰流感病毒血凝素分子的构象变化作为一种可能的中和机制。
Vaccine. 1985 Sep;3(3 Suppl):219-22. doi: 10.1016/0264-410x(85)90110-0.
5
Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?单克隆抗体与流感病毒血凝素上不同抗原区域的二价结合对于中和病毒感染性是否必要?
Arch Virol. 1985;85(3-4):209-16. doi: 10.1007/BF01314232.
6
Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus.用针对A/海豹/马萨诸塞州/1/80(H7N7)流感病毒血凝素分子上不同抗原区域的单克隆抗体抑制病毒诱导的溶血反应。
Arch Virol. 1983;76(2):91-9. doi: 10.1007/BF01311693.
7
An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.针对流感病毒血凝素表位的单克隆抗体特性分析。
Arch Virol. 1990;114(1-2):1-26. doi: 10.1007/BF01311008.
8
Quantitative relationships between an influenza virus and neutralizing antibody.流感病毒与中和抗体之间的定量关系。
Virology. 1987 Aug;159(2):288-98. doi: 10.1016/0042-6822(87)90466-1.
9
Conformational changes at topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies.甲型流感病毒A/PR/8/34血凝素(HA)分子上拓扑结构不同的抗原位点的构象变化是由单克隆抗体的结合诱导产生的。
Virology. 1982 Apr 15;118(1):1-7. doi: 10.1016/0042-6822(82)90313-0.
10
Monoclonal antibodies detect different forms of influenza virus hemagglutinin during viral penetration and biosynthesis.单克隆抗体在病毒穿透和生物合成过程中可检测到不同形式的流感病毒血凝素。
J Virol. 1985 Aug;55(2):307-13. doi: 10.1128/JVI.55.2.307-313.1985.

引用本文的文献

1
Strategies for fighting pandemic virus infections: Integration of virology and drug delivery.抗击病毒感染的策略:病毒学与药物输送的融合。
J Control Release. 2022 Mar;343:361-378. doi: 10.1016/j.jconrel.2022.01.046. Epub 2022 Feb 3.
2
Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine.Panblok-H1+Advax H1N1/2009pdm疫苗:关于菊粉δ佐剂重组大流行性流感疫苗快速研发的见解
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-11. doi: 10.1080/21645515.2017.1279765. Epub 2017 Feb 14.
3
Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.
Flublok预防成人季节性流感的安全性、有效性及免疫原性。
Ther Adv Vaccines. 2015 Jul;3(4):97-108. doi: 10.1177/2051013615595595.
4
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.随机临床试验免疫原性和安全性的一种重组 H1N1/2009 大流行性流感疫苗含有 Advax™多糖佐剂。
Vaccine. 2012 Aug 3;30(36):5407-16. doi: 10.1016/j.vaccine.2012.06.009. Epub 2012 Jun 17.
5
FluBlok, a recombinant hemagglutinin influenza vaccine.福路博克,一种重组血凝素流感疫苗。
Influenza Other Respir Viruses. 2008 Nov;2(6):211-9. doi: 10.1111/j.1750-2659.2008.00053.x.
6
Mapping antibody epitopes of the avian H5N1 influenza virus.绘制禽流感H5N1病毒的抗体表位
PLoS Med. 2009 Apr 21;6(4):e1000064. doi: 10.1371/journal.pmed.1000064.
7
Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.交叉反应性神经氨酸酶抗体可为小鼠提供针对H5N1的部分保护,且在未接触过该病毒的人体内也存在。
PLoS Med. 2007 Feb;4(2):e59. doi: 10.1371/journal.pmed.0040059.
8
Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.年轻人和老年人对灭活流感病毒疫苗的神经氨酸酶特异性抗体反应。
Clin Diagn Lab Immunol. 1996 Sep;3(5):511-6. doi: 10.1128/cdli.3.5.511-516.1996.
9
Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection.纯化的流感病毒血凝素和神经氨酸酶在刺激抗体反应方面相当,但诱导的感染免疫类型却截然不同。
J Virol. 1989 Mar;63(3):1239-46. doi: 10.1128/JVI.63.3.1239-1246.1989.
10
Insights into neutralization of animal viruses gained from study of influenza virus.从流感病毒研究中获得的关于动物病毒中和作用的见解。
Epidemiol Infect. 1991 Apr;106(2):205-20. doi: 10.1017/s0950268800048354.